A system-level approach for deciphering the transcriptional response to prion infection

Bioinformatics

Volumn 27, Issue 24, 2011, Pages 3407-3414

  Zampieri, Mattia ^a,b   Legname, Giuseppe ^b   Segrè, Daniel ^c,d,e   Altafini, Claudio ^b  

^a ETH ZURICH   (Switzerland)

^b SISSA   (Italy)

^c BOSTON UNIVERSITY   (United States)

^d Boston University   (United States)

^e Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PRION; PRION DISEASE;

ANIMALS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, GENETIC; PRION DISEASES; PRIONS; TRANSCRIPTION, GENETIC;

EID: 83355177201     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btr580     Document Type: Article

References (45)

1. Aguzzi, A. et al. (2008) The prion's elusive reason for being. Annu. Rev. Neurosci., 31, 439-477.
2. Bansal, M. et al. (2006) Inference of gene regulatory networks and compound mode of action from time course gene expression profiles. Bioinformatics, 22, 815-822.
3. Basso, K. et al. (2005) Reverse engineering of regulatory networks in human b cells. Nat. Genet., 37, 382-390.
4. Benetti, F. et al. (2010) Gene expression profiling to identify druggable targets in prion diseases. Exp. Opin. Drug Discov., 5, 177-202.
5. Berman, D.E. et al. (2008) Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat. Neurosci., 11, 547-554.
6. Bremer, J. et al. (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat. Neurosci., 13, 310-318.
7. Chesebro, B. et al. (2005) Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science, 308, 1435-1439.
8. di Bernardo, D. et al. (2005) Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat. Biotechnol., 23, 377-383.
9. Faith, J.J. et al. (2007) Large-scale mapping and validation of escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS Biol., 5.
10. Ferrer, I. et al. (1999) Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease. Neurobiol. Dis., 6, 92-100.
11. Fowler, D.M. et al. (2006) Functional amyloid formation within mammalian tissue. PLoS Biol., 4.
12. Gardner, T.S. et al. (2003) Inferring genetic networks and identifying compound mode of action via expression profiling. Science, 301, 102-105.
13. Goñi, J. et al. (2008) A computational analysis of protein-protein interaction networks in neurodegenerative diseases. BMC Syst. Biol., 2, 52.
14. Heinrich, S.U. and Lindquist, S. (2011) Protein-only mechanism induces selfperpetuating changes in the activity of neuronal aplysia cytoplasmic polyadenylation element binding protein (cpeb). Proc. Natl Acad. Sci. USA, 108, 2999-3004.
15. Hwang, D. et al. (2009)Asystems approach to prion disease. Mol. Syst. Biol., 5, 252-252.
16. Jensen, K. et al. (2008) Differences in the transcriptional responses induced by theileria annulata infection in bovine monocytes derived from resistant and susceptible cattle breeds. Int. J. Parasitol., 38, 313-325.
17. Kempster, S. et al. (2007) Simvastatin treatment prolongs the survival of scrapie-infected mice. Neuroreport, 18, 479-482.
18. Kim, B.H. et al. (2004) The cellular prion protein (prpc) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res. Mol. Brain Res., 124, 40-50.
19. Kocisko, D.A. et al. (2003) New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J. Virol., 77, 10288-10294.
20. Koperek, O. et al. (2002) Disease-associated prion protein in vessel walls. Am. J. Pathol., 161, 1979-1984.
21. Kourie, J.I. et al. (2003) Copper modulation of ion channels of prp[106-126] mutant prion peptide fragments. J. Membr. Biol., 193, 35-45.
22. Limviphuvadh, V. et al. (2007) The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs). Bioinformatics, 23, 2129-2138.
23. Li, X. et al. (2009) A mouse protein interactome through combined literature mining with multiple sources of interaction evidence. Amino Acids, 38, 1237-1252.
24. Nakamura, S. et al. (2000) Immunohistochemical detection of apolipoprotein E within prion-associated lesions in squirrel monkey brains. Acta Neuropathol., 100, 365-370.
25. Nico, P.B. et al. (2005) Altered behavioural response to acute stress in mice lacking cellular prion protein. Behav. Brain Res., 162, 173-181.
26. Pantera, B. et al. (2009) Prp© activation induces neurite outgrowth and differentiation in pc12 cells: role for caveolin-1 in the signal transduction pathway. J. Neurochem., 110, 194-207.
27. Prusiner, S.B. (1981) Disorders of glutamate metabolism and neurological dysfunction. Annu. Rev. Med., 32, 521-542.
28. Prusiner, S.B. (1982) Novel proteinaceous infectious particles cause scrapie. Science, 216, 136-144.
29. Radovanovic, I. et al. (2005) Truncated prion protein and doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J. Neurosci., 25, 4879-4888.
30. Roffé, M. et al. (2010) Prion protein interaction with stress-inducible protein 1 enhances neuronal protein synthesis via mTOR. Proc. Natl Acad. Sci. USA, 107, 13147-13152.
31. Ruepp, A. et al. (2010) Corum: the comprehensive resource of mammalian protein complexes-2009. Nucleic Acids Res., 38, 497-501.
32. Rutishauser, D. et al. (2009) The comprehensive native interactome of a fully functional tagged prion protein. PLoS One, 4.
33. Salès, N. et al. (2002) Developmental expression of the cellular prion protein in elongating axons. Eur. J. Neurosci., 15, 1163-1177.
34. Sandberg, M.K. and Löw, P. (2005) Altered interaction and expression of proteins involved in neurosecretion in scrapie-infected gt1-1 cells. J. Biol. Chem., 280, 1264-1271.
35. Santuccione, A.et al. (2005) Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J. Cell Biol., 169, 341-354.
36. Si, K. et al. (2003a) A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in aplysia. Cell, 115, 893-904.
37. Si, K. et al. (2003b) A neuronal isoform of the aplysia CPEB has prion-like properties. Cell, 115, 879-891.
38. Storey, J.D. (2002) A direct approach to false discovery rates. J. R. Stat. Soc. Ser. B, 64, 479-498.
39. Taraboulos, A. et al. (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell. Biol., 129, 121-132.
40. Taylor, D.R. and Hooper, N.M. (2007) The low-density lipoprotein receptor-related protein 1 (lrp1) mediates the endocytosis of the cellular prion protein. Biochem. J., 402, 17-23.
41. Trevitt, C.R. and Collinge, J. (2006) A systematic review of prion therapeutics in experimental models. Brain, 129(Pt 9), 2241-2265.
42. Wang, K. et al. (2009) Genome-wide identification of post-translational modulators of transcription factor activity in human B cells. Nat. Biotechnol., 27, 829-839.
43. Watts, J.C. et al. (2009) Interactome analyses identify ties of PRP and its mammalian paralogs to oligomannosidic n-glycans and endoplasmic reticulumderived chaperones. PLoS Pathog., 5.
44. Yehiely, F. et al. (1997)Identification of candidate proteins binding to prion protein. Neurobiol. Dis., 3, 339-355.
45. Zampieri, M. et al. (2008) Origin of co-expression patterns in E. coli and S. cerevisiae emerging from reverse engineering algorithms. PLoS One, 3.